Medivolve Inc. (MEDVF)
USD 0.01
(133.33%)
USD 0.01
(133.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 686.45 Thousand | 37.17 Million | 86.82 Million | 1.47 Million | -152.1 Thousand | 17.64 Thousand |
| Cost of Revenue | 111.1 Thousand | 22.78 Million | 50.25 Million | 5.97 Million | 1.04 Million | - |
| Gross Profit | 575.35 Thousand | 14.38 Million | 36.56 Million | -4.5 Million | -1.19 Million | 17.64 Thousand |
| Operating Expenses | 4.11 Million | 26.89 Million | 22.85 Million | 13.15 Million | 2.42 Million | 1 Million |
| Selling, General and Administrative Expenses | 3.59 Million | 26.38 Million | 21.64 Million | 9.85 Million | 2.27 Million | 878.3 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 564.86 Thousand | - | -1.28 Million | - | -1.37 Million | - |
| Cost and Expenses | 4.26 Million | 49.68 Million | 73.11 Million | 19.13 Million | 2.42 Million | 1 Million |
| Operating Income | -3.58 Million | -22.79 Million | 1.17 Million | -22.19 Million | -2.38 Million | -1.28 Million |
| Interest Expense | - | 238.03 Thousand | 482.7 Thousand | 86.94 Thousand | - | - |
| Income Tax Expense | - | -4.51 Million | 6.45 Million | 86.94 Thousand | -2.21 Million | -298.14 Thousand |
| Earnings before Tax | -3.91 Million | -22.87 Million | -154.03 Thousand | -37.77 Million | -2.71 Million | -711.56 Thousand |
| Net Income | -16.45 Million | -18.36 Million | -6.61 Million | -37.77 Million | -2.71 Million | -711.56 Thousand |
| Earnings Per Share Basic | -0.03 | -0.68 | -0.34 | -5.66 | -1.19 | -0.31 |
| Earnings Per Share Diluted | -0.14 | -0.68 | -0.34 | -5.66 | -1.19 | -0.31 |
| Weighted Average Shares Outstanding | 120.08 Million | 27.01 Million | 19.32 Million | 6.67 Million | 2.27 Million | 2.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.01 Million | 27.01 Million | 19.32 Million | 6.67 Million | 2.27 Million | 2.27 Million |
| Gross Margin | 0.84 | 0.39 | 0.42 | -3.05 | 7.88 | 1.00 |
| EBIT Margin | -4.33 | -0.02 | 0.20 | -12.89 | 15.66 | -72.95 |
| Profit Margin | -23.98 | -0.49 | -0.08 | -25.60 | 17.87 | -40.33 |
| EBITDA | -2.97 Million | -11.56 Million | 18.53 Million | -19.01 Million | -2.38 Million | -920.84 Thousand |
| Earnings Before Tax Margin | -5.22 | -0.61 | 0.01 | -15.04 | 15.66 | -72.95 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 288.78 Thousand | 256.01 Thousand | 686.45 Thousand | 182.62 Thousand | 193.55 Thousand | 1.43 Million |
| Cost of Revenue | 26.28 Thousand | 39.27 Thousand | 111.1 Thousand | 46.11 Thousand | -198.95 Thousand | 768.68 Thousand |
| Gross Profit | 262.49 Thousand | 216.73 Thousand | 575.35 Thousand | 136.51 Thousand | 392.5 Thousand | 664.14 Thousand |
| Operating Expenses | 729.96 Thousand | 764.41 Thousand | 3.94 Million | 1.29 Million | 2.62 Million | 3 Million |
| Selling, General and Administrative Expenses | 635.82 Thousand | 667.22 Thousand | - | 1.18 Million | 1.66 Million | 2.19 Million |
| Research and Development Expenses | - | 380.00 | - | - | - | - |
| Other Expenses | 94.14 Thousand | - | - | - | - | - |
| Cost and Expenses | 756.25 Thousand | 803.69 Thousand | 4.05 Million | 1.33 Million | 2.42 Million | 3.77 Million |
| Operating Income | -601.83 Thousand | -501.25 Thousand | -3.58 Million | -1.33 Million | -2.35 Million | -2.35 Million |
| Interest Expense | 6275.00 | - | - | 77.91 Thousand | 116.19 Thousand | 64.67 Thousand |
| Income Tax Expense | 279.03 Thousand | 8.16 Million | 13.08 Million | 2.48 Million | 95.73 Thousand | 23.3 Thousand |
| Earnings before Tax | -659.24 Thousand | -530.09 Thousand | -3.91 Million | -1.1 Million | -1.68 Million | -2.88 Million |
| Net Income | -931.99 Thousand | -8.37 Million | -16.45 Million | -3.5 Million | -1.66 Million | -2.91 Million |
| Earnings Per Share Basic | -0.03 | -0.31 | - | -0.13 | -0.06 | -0.11 |
| Earnings Per Share Diluted | -0.03 | -0.31 | - | -0.13 | -0.06 | -0.11 |
| Weighted Average Shares Outstanding | 27.01 Million | 27.02 Million | 27.01 Million | 27.01 Million | 27.01 Million | 27.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.01 Million | 27.01 Million | 27.01 Million | 27.01 Million | 27.01 Million | 27.01 Million |
| Gross Margin | 0.91 | 0.85 | 0.84 | 0.75 | 2.03 | 0.46 |
| EBIT Margin | -1.44 | -0.98 | - | -6.05 | -11.20 | -1.52 |
| Profit Margin | -3.23 | -32.71 | -23.98 | -19.21 | -8.59 | -2.03 |
| EBITDA | -416.27 Thousand | -249.98 Thousand | - | -1.1 Million | -2.16 Million | -2.17 Million |
| Earnings Before Tax Margin | -2.08 | -1.96 | -5.22 | -7.31 | -12.16 | -1.64 |
BNORDIK-CSE
MLEDU
688595
603519
CABB
DGL